Whether it's the corporate lunchroom, your cubicle, or the local watering hole after work, there are regular places we gather to discuss news, sports, or -- if you're like us -- stocks. Here at Motley Fool CAPS, we gather around the virtual water cooler daily to rate stocks and delve into their merits as investments.

Our 130,000-strong CAPS community -- where members give the thumbs-up or thumbs-down to about 5,200 stocks -- has earned its points by seeking out the businesses it thinks will outperform the market. Below, we'll take a look at stocks in the CAPS universe that you're talking about the most and whether you think they'll continue their winning ways.

Stock

CAPS Rating
(out of 5 stars)

No. of Calls

% Outperform Calls

Akamai Technologies (NASDAQ:AKAM)

*****

2,599

96%

American Oriental Bioengineering (NYSE:AOB)

*****

2,832

97%

China Mobile (NYSE:CHL)

*****

3,179

97%

Sony (NYSE:SNE)

**

1,535

70%

Sun Microsystems (NASDAQ:JAVA)

**

1,698

83%

A tall drink of water
Did you feel it? The palpable loss of control when Google (NASDAQ:GOOG) experienced an outage last week and 14% of its users were unable to access the system. Well, googlefail became the top phrase on Twitter. Although a cloud briefly passed over cloud computing, it wasn't a gathering storm, but rather more like a sun shower. Google had the situation pretty much in hand shortly thereafter. I'm not sure if it's related, but I've experienced spotty service since and have run into plenty of short-term issues with gmail and accessing news servers, even this morning.

Despite the fuzzy reception, more companies continue to deliver content via the cloud than ever before, and more often than not, that means Akamai Technologies will report more winning quarters like the latest one. Even with smaller businesses experiencing a recessionary crunch, the optimization leader is perhaps one of the few companies that's able to effectively support the growing number of vendors looking to use a cloud computing environment.

As CAPS member joats5 notes, Akamai has been such a consistent performer, analysts are still behind it even after they've been proven wrong (such as what happened with a Goldman Sachs (NYSE:GS) analyst who admitted he missed the strength of overseas expansion).

Great innovative products in a market with huge growth potential, fundamentals look very sound, high degree of institutional ownership, low debt, consistantly meet or beat earnings estimates. It's hard to find any pro or ratings agency that doesn't think this company is poised for significant growth.

Akamai shares are trading well above the lows they reached back in November -- up nearly 70% over the past six months. Earnings grew 40% for 2008 and Wall Street estimates earnings will grow 13% or more annually over the long haul, yet the company trades for just about 12 times forward earnings. Any further pullback in the stock's share price, similar to what happened earlier this month, is likely to make investors view it as a great buying opportunity.

Gather 'round
With so many good opinions about today's top companies, why not grab a pointy paper cup from the dispenser and join us at the Motley Fool CAPS water cooler, where your input can help guide other investors to stocks with bright prospects? Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made -- all from a stock's CAPS page.

Sign up today for the completely free service and let us hear what you have to say about the great and almost-great companies that interest you.

Akamai Technologies and Google are Motley Fool Rule Breakers recommendations. American Oriental Bioengineering is a Motley Fool Global Gains and a Motley Fool Hidden Gems recommendation. The Fool owns shares of American Oriental Bioengineering. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings. The Motley Fool has a disclosure policy.